poisar

Stocks · News reference

BioCryst to Report Third Quarter 2026 Financial Results on November 4

Fiscal.ai

BioCryst Pharmaceuticals, Inc. announced it will release its financial results for the third quarter of 2026 on November 4, 2026, followed by a conference call and webcast.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
fiscal.ai
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. SEC EDGARSEC EDGAR

    8-K filing — BIOCRYST PHARMACEUTICALS INC (BCRX)

    Filed: 2026-11-04 AccNo: 0001171843-26-007097 Size: 451 KB Item 2.02: Results of Operations and Financial Condition Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits